GSK, U.K. researchers to search for drug to fight vCJD

04/13/2005 | Reuters

GlaxoSmithKline plans to work with Britain's Medical Research Council to search for a drug that can be used against the human version of BSE, vCJD. Researchers will screen drug-like molecules in GSK's vast library of compounds in hopes of finding a compound that can enter the brain and bind to the normal prion, preventing it from transforming into an infectious agent.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA